Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NIOCORP DEVELOPMENTS LTD Director's Dealing 2022

Nov 29, 2022

32677_dirs_2022-11-29_72424d3c-ca4e-4a07-9989-7d9c2a65d66b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NIOCORP DEVELOPMENTS LTD (NIOBF)
CIK: 0001512228
Period of Report: 2022-11-28

Reporting Person: Guerrero-Mahon Nilsa (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-28 Common Shares M 500000 $0.3513 Acquired 500000 Direct
2022-11-28 Common Shares F 200855 $0.8746 Disposed 299145 Direct
2022-11-28 Common Shares M 300000 $0.4037 Acquired 599145 Direct
2022-11-28 Common Shares F 138462 $0.8746 Disposed 460682 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-28 Director Stock Option (right to buy) $0.3513 M 500000 Disposed 2022-11-30 Common Shares (500000) Direct
2022-11-28 Director Stock Option (right to buy) $0.4037 M 300000 Disposed 2023-11-15 Common Shares (300000) Direct

Footnotes

F1: Option exercise price reflected was converted from Canadian exercise price of C$0.47 using an exchange rate of C$1.3377 = US$1.00 as reported by the Bank of Canada on November 25, 2022.

F2: Sale price of common shares withheld in satisfaction of option exercise price is based on the closing price of the common shares on the Toronto Stock Exchange on November 25, 2022 of C$1.17, which was converted using an exchange rate of C$1.3377 = US$1.00 as reported by the Bank of Canada on November 25, 2022.

F3: Option exercise price reflected was converted from Canadian exercise price of C$0.54 using an exchange rate of C$1.3377 = US$1.00 as reported by the Bank of Canada on November 25, 2022.

F4: The option, representing a right to purchase a total of 500,000 Common Shares, became exercisable on the issuance date of November 9, 2017.

F5: The option, representing a right to purchase a total of 300,000 Common Shares, became exercisable in installments as follows: 50% on May 15, 2019; 25% on November 15, 2019; and 25% on May 15, 2020.